DALLAS, Aug. 7 — Starting statin therapy as young as age 8 safely and effectively delays the early artery damage caused by familial hypercholesterolemia (FH), according to a Dutch study reported in the Aug. 7th print issue of Circulation: Journal of the American Heart Association.“Our data support early initiation of statin therapy in FH children, which might yield a larger benefit in the prevention of atherosclerosis later in life,” said Barbara A. Hutten, Ph.D., senior author of the study. “In our opinion, physicians should consider statin treatment for all FH children who are 8 or older.”
